|
|
|
18 Aug 2008 |
Repros Therapeutics Inc. Provides Update for US Phase II Endometriosis Study and Completion of QT Interval Dose Selection Screen
|
|
16 Aug 2008 |
OrthoLogic Announces Completion of Dosing for Second AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
|
|
13 Aug 2008 |
Lexicon Pharmaceuticals Identifies New Drug Candidate for Glaucoma
|
|
12 Aug 2008 |
Oxygen Biotherapeutics Develops Gel Version of Oxycyte(R) for Treating Surface Wounds
|
|
12 Aug 2008 |
Bronchinol Cystic Fibrosis Dose Trial Results Positive
|
|
11 Aug 2008 |
Enrollment in Phase IIb Clinical Trial for I-vation(TM) TA (MK-0140) Suspended Pending Review of Study Design by Merck & Co., Inc.
|
|
10 Aug 2008 |
FDA Allows Phase 2 Study for Sound Pharmaceuticals' Novel Drug to Prevent Chemotherapy Induced Hearing Loss
|
|
06 Aug 2008 |
Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
|
|
06 Aug 2008 |
Xanodyne Pharmaceuticals, Inc. Achieves Positive Efficacy Results in Pivotal Phase 3 Studies of Proprietary Modified Release Oral Tranexamic Acid Product Candidate for Heavy Menstrual Bleeding
|
|
05 Aug 2008 |
Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate
|
|
03 Aug 2008 |
U.S. FDA Issues Action Letter for Sugammadex
|
|
31 Jul 2008 |
MediGene Sells Licensee Rights To The Drug Oracea(R) To Galderma
|
|
31 Jul 2008 |
Othera Files IND Application for OT-730 in Glaucoma
|
|
31 Jul 2008 |
Regulatory approval of Basilea’s Toctino(R) (alitretinoin) recommended by concerned EU Member States
|
|
31 Jul 2008 |
Preclinical Data for a Topical Formulation of Voclosporin as a Potential Best-in-Class Treatment for Chronic Inflammatory Eye Diseases Presented at ARVO
|
|
31 Jul 2008 |
Neuropharma reports last results on its research in Alzheimer’s disease, at the International Conference of Alzheimer’s Disease held in Chicago on July 26-31
|
|
30 Jul 2008 |
Medgenics Granted Approval to Commence Its Landmark Phase I/II Clinical Study of Epodure to Treat Anemia
|
|
30 Jul 2008 |
Quark Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in DME
|
|
30 Jul 2008 |
BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
|
|
30 Jul 2008 |
Cytochroma and Mitsubishi Tanabe Form Partnership for Chronic Kidney Disease Therapies in U.S. and Asia
|
|
29 Jul 2008 |
Lexicon Pharmaceuticals' Drug Candidate for Irritable Bowel Syndrome Completes Phase 1 Clinical Trial Showing Positive Results
|
|
29 Jul 2008 |
Inspire Provides Update on Cystic Fibrosis Clinical Program
|
|
29 Jul 2008 |
European Commission Grants Marketing Authorization for MediGene's Drug Oracea
|
|
28 Jul 2008 |
Omrix Biopharmaceuticals Receives Positive Opinion from Committee for Medicinal Products for Human Use (CHMP) for Evicel(TM) Liquid Fibrin Sealant (Human)
|
|
28 Jul 2008 |
Vyteris Announces Successful Completion of Peptide Dose Ranging Study in Preparation for Phase II Human Clinical Trials
|
|
27 Jul 2008 |
XOMA Begins Phase 2a Clinical Trial to Evaluate XOMA 629 Topical Gel as a Treatment for the Common Skin Disease, Impetigo
|
|
26 Jul 2008 |
Sound Pharmaceuticals, Inc. Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
|
|
24 Jul 2008 |
Nexmed Receives FDA Response for Ed Product
|
|
23 Jul 2008 |
TOPIGEN Pharmaceuticals Completes Enrollment of Phase II Clinical Study of TPI ASM8 in Asthma
|
|
17 Jul 2008 |
Meditrina Pharmaceuticals, Inc. opens Investigational New Drug (IND) application for phase IIb clinical trial with MPI-676 in endometriosis
|
|
17 Jul 2008 |
Repros Therapeutics Inc. Announces That Proellex(R) Administered to Patients as Cyclic Therapy to Treat the Symptoms of Uterine Fibroids for Up to 30 Months Shows No Adverse Effects on the Endometrium
|
|
15 Jul 2008 |
EyeGate Pharma Initiates Landmark Clinical Study Employing the EyeGate(R) II Non-Invasive Ocular Delivery System in Acute Anterior Uveitis
|
|
15 Jul 2008 |
Theravance Announces Positive Phase 2 Clinical Results in the MABA Respiratory Program for the Treatment of COPD
|
|
15 Jul 2008 |
Theravance Announces Clinical Results in the LAMA Respiratory Program for the Treatment of COPD
|
|
13 Jul 2008 |
Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
|
|
13 Jul 2008 |
Repros Therapeutics Inc. Announces That Proellex Significantly Reduces Pain in a U.S. Phase 2 Clinical Trial in Women with Moderate to Severe Endometriosis
|
|
10 Jul 2008 |
OrthoLogic Announces Initiation of Dosing for Second AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
|
|
10 Jul 2008 |
Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Oral Zinthionein for Dry Age-Related Macular Degeneration (AMD)
|
|
10 Jul 2008 |
Sosei Announces Completion of Phase III Trial for NorLevo(R)
|
|
09 Jul 2008 |
Affymax Completes Enrollment in PEARL 1, the First of Four Phase 3 Clinical Trials of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients
|
|
08 Jul 2008 |
Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
|
|
06 Jul 2008 |
Sentek Announces Termination of Invicorp(R) Licensse Agreement With Ardana Bioscience Limited
|
|
03 Jul 2008 |
Wyeth and Progenics Receive Approval from European Commission for RELISTOR for Opioid-Induced Constipation in Advanced Illness Patients
|
|
03 Jul 2008 |
ARYx Therapeutics, Inc. Announces Procter & Gamble Exercises Option to End Collaboration on ATI-7505
|
|
03 Jul 2008 |
Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
|
|
03 Jul 2008 |
Evotec's EVT 101 Well Tolerated in Four Week Higher Repeat Dose Safety Study
|
|
03 Jul 2008 |
ARYx Therapeutics, Inc. Announces Successful Results of QT Study on ATI-7505
|
|
03 Jul 2008 |
VAVELTA(R) Phase II data presented at FACE
|
|
02 Jul 2008 |
Omrix Biopharmaceuticals Initiates Phase II Clinical Trial in Israel for Fibrin Pad Product Candidate
|
|
02 Jul 2008 |
Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
|
| |
|
Results 101 - 150 of 985 |
